The goal of this clinical trial is to determine whether adding magnesium sulfate or tramadol to intrathecal bupivacaine improves postoperative pain control and hemodynamic stability in adult male patients undergoing transurethral resection of the prostate (TURP). The main questions this study aims to answer are: Does the addition of magnesium sulfate or tramadol prolong the duration of postoperative analgesia compared to bupivacaine alone? Does either adjuvant provide better intraoperative hemodynamic stability? Researchers will compare two groups: One group receiving magnesium sulfate plus bupivacaine Another group receiving tramadol plus bupivacaine to see which combination is more effective for pain control and hemodynamic outcomes. Participants will: Receive spinal anesthesia with either magnesium sulfate or tramadol added to bupivacaine. Be monitored during surgery for heart rate, blood pressure, and other vital signs. Be assessed after surgery for pain levels and time until first request for additional pain medication.
Age range
50 Years – 80 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Duration of postoperative analgesia
Timeframe: Up to 24 hours postoperatively